Advertisement
Screener

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

1.8 / 5 stars · 14/40 Roast Me

SCINAI IMMUNOTHERAPEUTICS LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $12.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-04-01

  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
  • 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
2025-12-31$12.00K
20-F · filed 2026-04-01
2024-12-31$12.00K
20-F · filed 2026-04-01
2023-12-31$12.00K
20-F · filed 2025-05-07
2022-12-31$12.00K
20-F · filed 2024-05-15
2021-12-31$85.00K
10-K · filed 2023-04-17